title: Frequent early multiple sclerosis relapses during treatment with fingolimod: a paradoxical effect?
authors.affiliation: Department of Neurosciences, University of Modena and Reggio Emilia, Italy.
authors.forename: D
authors.initials: D
authors.lastname: Ferraro
authors.forename: L
authors.initials: L
authors.lastname: Federzoni
authors.forename: F
authors.initials: F
authors.lastname: Vitetta
authors.forename: Am
authors.initials: A
authors.lastname: Simone
authors.forename: A
authors.initials: A
authors.lastname: Cossarizza
authors.forename: Pf
authors.initials: P
authors.lastname: Nichelli
authors.forename: P
authors.initials: P
authors.lastname: Sola
mesh_terms: D001921:Brain / Q000473:pathology*; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects*; D008297:Male; D009471:Neuromyelitis Optica / Q000188:drug therapy* / Q000473:pathology*; D011409:Propylene Glycols / Q000009:adverse effects*; D013110:Sphingosine / Q000031:analogs & derivatives*
chemical_list: D007166:Immunosuppressive Agents; D011409:Propylene Glycols; D013110:Sphingosine